US$ 20.97
bpc-157 for gastological issues ORAL The Hidden Risks of BPC‑157:
Description
Free shipping over $199 Research-grade GHK-Cu 100mg lyophilised powder 99.3% HPLC purity, COA verified

1 The KESIMPTA Phase 2 trial determined that once monthly frequency in a low SC dose was comparably effective, with fewer side effects, vs higher SC doses

Nephrol., 42: 148-167

First isolated from human plasma in 1973, this compound is distinguished by its high affinity for copper(II) ions, which gives the lyophilized powder and reconstituted solution its signature blue coloration

Kalmbacher for personalized advice

The animal study was approved by Ethical Committees of the Instituto de Biologa y Medicina Experimental, Buenos Aires #24/2021
